NCL Technology Ventures is a VC firm that helps generate returns to investors through investing in in early stage disruptive healthcare start-ups just before their inflection-point in commercial value.

The healthcare sector presents a significant opportunity for early stage investment as the industry is being transformed by a step change in technology. The UK offers a unique combination of world class scientific heritage, undervalued assets and a leading healthcare system. NCL’s Health Technology Fund has privileged access to deal flow from prominent centers of healthcare excellence.

Alongside global industry partners, NCL’s specialist team identifies, validates and rapidly accelerates market deployment of technologies into the healthcare system. Our most promising companies are guided towards the US market, where they can benefit from significant value uplifts, deeper pools of liquidity and greater exit opportunities.

NCL takes an active approach seeking to invest early where we can see great potential, nurturing both companies and entrepreneurs from seed through to exit. Our investments seek to produce outstanding returns for our investors whilst maximising positive impact for patients, caregivers and providers.